The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Technology
  • Automotive
  • Arts
  • Marketing

Lineus Medical Receives Innovative Technology Contract from Vizient for SafeBreak® Vascular
The PennZone/10180170

Trending...
  • NFL Midseason 2025: Who's for Real and Who's Faking It?
  • Jonathan Malveaux Named Newest Member of Forbes Business Council
  • PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education
Lineus Medical
Contract awarded for products that bring improvement to health care industry

FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.

More on The PennZone
  • Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
  • 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
  • uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
  • Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
  • Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch

"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.

"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

More on The PennZone
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
  • Diamond Wealth Advisors Experience the New York Stock Exchange and Ring the Closing Bell
  • $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges

###

Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.

MKG-0135 Rev. 00

Source: Lineus Medical
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Kaltra Offers Microchannel Condensers Optimized for Low-GWP Refrigerants R454B, R32, and R290
  • Putting Your Roses to Bed for Winter in the Deep South - A Gentleman's Guide to Fall Rose Care
  • Tens of Thousands Complete Course to Master Entire Bible, Including Revelation
  • UK Financial Ltd Unveils The First ERC-3643 Security Token Born from a Meme: Introducing MayaCat Regulated Security Token (SMCAT) Successor to MayaCat
  • Kaplan Morrell Law Firm Represents Former NHL Player in Workers' Compensation Case Drawing National Attention
  • Local Lighting Experts Debut AI Christmas Decorator: Upload a Photo, Get Instant Professional Holiday Design-- Completely Free
  • Surf Air Mobility (N Y S E: SRFM) Accelerates Regional Air Mobility Revolution with Electra Aero Partnership, Palantir Alliance, and Record Revenue
  • Cybersecurity is Fast Becoming a Vital Issue for Protecting Personal Information and Portfolio Wealth
  • 10 Essential Tips for Maximizing Value When Choosing Your Orlando Wedding Venue
  • Americans Are Trading Offices for Beaches: How Business Ownership Enables the Ultimate Location Freedom
  • Boston Industrial Solutions' Natron® DC Series Ink Has Had an Upgrade!
  • Colony Ridge Proudly Supports the All Ears! 2025 Sporting Clays Tournament
  • Jacob Emrani Nominated for LA Executive Award
  • VIP Vacations Named One of Top Travel Agencies
  • Kansas City Steak Company Shares the Return of Their Holiday Gift Box
  • Dr. Jay A. Johannigman Delivers Lecture at the John R. Border Memorial Lectureship in Buffalo
  • Powering the Next Frontier of the $1 Trillion Space Economy: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Taikan's T-V856S VMC Earns Prestigious 2025 Vogel Global Pioneer Award
  • Flick Truck Accident Law Joins the Commercial Vehicle Safety Alliance to Strengthen Truck Safety Advocacy
  • PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education

Popular on PennZone

  • New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them - 460
  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 382
  • Some Music for Donald's Bad Day
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Hiclean Tools Releases HCX2100 Electric Pressure Washer
  • SprintRay Retainers and DIBS AI Braces in Reading Improve Precision and Patient Experience
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • Wedding Bells: Newlyweds Rush to Try Simple QR Code 'Photo Hack' That's Taking the Stress Out of Wedding Memories
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"

Similar on PennZone

  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • Dr. Jay A. Johannigman Delivers Lecture at the John R. Border Memorial Lectureship in Buffalo
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us